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Background: The ratio of peak tricuspid regurgitation velocity to the time velocity integral of the right ventricular outflow tract (TRV/TVIRVOT) 
distinguishes elevated versus normal invasive pulmonary vascular resistance (PVRcath). We aim to validate TRV/TVIRVOT as a correlate of PVRcath 
and compare TRV/TVIRVOT to a modified ratio, TRV2/TVIRVOT, in patients with markedly elevated PVR > 6WU. 
methods: Data from 5 international studies comparing non-invasive assessments of PVR using TRV/ TVIRVOT (PVRecho1) to PVRcath were 
collected. Multiple linear regression analyses were generated between PVRcath and both TRV/TVIRVOT and TRV2/TVIRVOT. Bland Altman analysis was 
performed for PVRcath and PVRecho1 and the new regression equation, TRV2/TVIRVOT (PVRecho2). An ROC was obtained for TRV/TVIRVOT to predict 
PVR > 6 WU.
results: 150 patients were included. There was better correlation between PVRcath and TRV2/TVIRVOT (r = 0.79, p < 0.0001, Z = -0.01) versus 
TRV/TVIRVOT (r = 0.76, p < 0.0001, Z = 0.92) (Figure 1), especially with PVR > 6WU. PVRecho2 compared better with PVRcath than PVRecho1 when 
PVRcath was > 6 WU on Bland Altman (mean 2.06, SD 3.93 versus mean 6.35, SD 3.75) (Figure 2). TRV/TVIRVOT > 0.275 predicted PVRcath > 6WU.
conclusions: Both TRV/TVIRVOT and TRV2/TVIRVOT identify patients with elevated PVRcath. With PVR > 6 WU, PVRecho2 provides an improved 
non-invasive estimate of PVRcath compared with PVRecho1.
 
